Assyro AI

Orange Book product · Generic (ANDA)

AMPHETAMINE SULFATE

AMPHETAMINE SULFATE

Generic (ANDA)ANDA 213852DISCN RHODES PHARMS

At a glance

Sep 07, 2021

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Sep 07, 2021

    4 yr 10 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

AMPHETAMINE SULFATE

Strength

5MG

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

ANDA 213852

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of AMPHETAMINE SULFATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.